We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed at $378.81 in the latest trading session, marking a +2.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.6% for the day. At the same time, the Dow added 0.83%, and the tech-heavy Nasdaq gained 0.64%.
Heading into today, shares of the largest U.S. health insurer had lost 4.46% over the past month, lagging the Medical sector's loss of 1.97% and the S&P 500's gain of 1.34%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. The company is slated to reveal its earnings on October 13, 2026. The company is predicted to post an EPS of $4.12, indicating a 41.1% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $111.38 billion, down 1.57% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $19.85 per share and revenue of $446.78 billion. These results would represent year-over-year changes of +21.41% and -0.18%, respectively.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.15% increase. As of now, UnitedHealth Group holds a Zacks Rank of #2 (Buy).
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 18.69. Its industry sports an average Forward P/E of 20.83, so one might conclude that UnitedHealth Group is trading at a discount comparatively.
One should further note that UNH currently holds a PEG ratio of 1.39. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. By the end of yesterday's trading, the Medical - HMOs industry had an average PEG ratio of 1.39.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 43, placing it within the top 18% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know
UnitedHealth Group (UNH - Free Report) closed at $378.81 in the latest trading session, marking a +2.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.6% for the day. At the same time, the Dow added 0.83%, and the tech-heavy Nasdaq gained 0.64%.
Heading into today, shares of the largest U.S. health insurer had lost 4.46% over the past month, lagging the Medical sector's loss of 1.97% and the S&P 500's gain of 1.34%.
The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. The company is slated to reveal its earnings on October 13, 2026. The company is predicted to post an EPS of $4.12, indicating a 41.1% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $111.38 billion, down 1.57% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $19.85 per share and revenue of $446.78 billion. These results would represent year-over-year changes of +21.41% and -0.18%, respectively.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.15% increase. As of now, UnitedHealth Group holds a Zacks Rank of #2 (Buy).
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 18.69. Its industry sports an average Forward P/E of 20.83, so one might conclude that UnitedHealth Group is trading at a discount comparatively.
One should further note that UNH currently holds a PEG ratio of 1.39. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. By the end of yesterday's trading, the Medical - HMOs industry had an average PEG ratio of 1.39.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 43, placing it within the top 18% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.